Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target

Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.

Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.

Total
0
Shares
Related Posts